NASDAQ:DRTS Alpha Tau Medical (DRTS) Stock Price, News & Analysis → Your Special Report - Top 7 Summer Stocks (From StockEarnings) (Ad) Free DRTS Stock Alerts $2.30 -0.08 (-3.36%) (As of 06/11/2024 ET) Add Compare Share Share Today's Range$2.30▼$2.3550-Day Range$2.30▼$2.9052-Week Range$2.15▼$4.55Volume20,197 shsAverage Volume33,312 shsMarket Capitalization$160.24 millionP/E RatioN/ADividend YieldN/APrice Target$12.00 Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends Alpha Tau Medical MarketRank™ Stock AnalysisAnalyst RatingBuy3.00 Rating ScoreUpside/Downside421.7% Upside$12.00 Price TargetShort InterestHealthy0.05% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews SentimentN/AInsider TradingN/AProj. Earnings GrowthDecreasingFrom ($0.50) to ($0.54) Per ShareSee Full Details Hide Full Details Overall MarketRank™New Rank-Based ScoringMarketRank™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.2.48 out of 5 starsMedical Sector409th out of 905 stocksSurgical & Medical Instruments Industry53rd out of 99 stocks 3.5 Analyst's Opinion Consensus RatingAlpha Tau Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 4 buy ratings, no hold ratings, and no sell ratings.Amount of Analyst CoverageAlpha Tau Medical has only been the subject of 1 research reports in the past 90 days.Read more about Alpha Tau Medical's stock forecast and price target. Previous Next 5.0 Short Interest Percentage of Shares Shorted0.05% of the float of Alpha Tau Medical has been sold short.Short Interest Ratio / Days to CoverAlpha Tau Medical has a short interest ratio ("days to cover") of 0.8, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Alpha Tau Medical has recently decreased by 6.92%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldAlpha Tau Medical does not currently pay a dividend.Dividend GrowthAlpha Tau Medical does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for DRTS. Previous Next 2.8 News and Social Media Coverage News SentimentAlpha Tau Medical has a news sentiment score of 0.98. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for Alpha Tau Medical this week, compared to 0 articles on an average week.Search InterestOnly 1 people have searched for DRTS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows3 people have added Alpha Tau Medical to their MarketBeat watchlist in the last 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Alpha Tau Medical insiders have not sold or bought any company stock.Percentage Held by Insiders39.50% of the stock of Alpha Tau Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 2.65% of the stock of Alpha Tau Medical is held by institutions.Read more about Alpha Tau Medical's insider trading history. Previous Next 0.0 Earnings and Valuation Earnings GrowthEarnings for Alpha Tau Medical are expected to decrease in the coming year, from ($0.50) to ($0.54) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Alpha Tau Medical is -5.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Alpha Tau Medical is -5.61, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioAlpha Tau Medical has a P/B Ratio of 1.90. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Alpha Tau Medical's valuation and earnings. Previous Next See Top Rated MarketRank™ Stocks Here Ad Stansberry ResearchWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.Learn more here. About Alpha Tau Medical Stock (NASDAQ:DRTS)Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, prostate, and breast cancers; and preclinical studies for brain, hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.Read More DRTS Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart DRTS Stock News HeadlinesJune 4, 2024 | americanbankingnews.comAlpha Tau Medical Ltd. (NASDAQ:DRTS) Short Interest Down 6.9% in MayMay 21, 2024 | markets.businessinsider.comPiper Sandler Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)May 21, 2024 | globenewswire.comAlpha Tau to Present at the Jefferies Global Healthcare ConferenceMay 21, 2024 | finanznachrichten.deAlpha Tau Medical Ltd.: Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 20, 2024 | globenewswire.comAlpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate UpdateMay 13, 2024 | globenewswire.comAlpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal CancerMay 6, 2024 | globenewswire.comAlpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in GlasgowMay 1, 2024 | globenewswire.comAlpha Tau to Participate in May Investor ConferencesMarch 25, 2024 | globenewswire.comAlpha Tau to Present at the Jefferies Radiopharma Innovation SummitMarch 12, 2024 | markets.businessinsider.comBuy Rating Affirmed: Anticipating Alpha Tau Medical’s Clinical Milestones and Growth Potential in 2024March 7, 2024 | globenewswire.comAlpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate UpdateFebruary 26, 2024 | globenewswire.comAlpha Tau to Participate in Barclays 26th Annual Global Healthcare ConferenceJanuary 8, 2024 | benzinga.comAlpha Tau Medical Stock (NASDAQ:DRTS), Quotes and News SummaryDecember 20, 2023 | finance.yahoo.comAlpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceNovember 28, 2023 | finance.yahoo.comAlpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic CancerNovember 20, 2023 | finance.yahoo.comAlpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck CancerNovember 17, 2023 | markets.businessinsider.comAnalyst Ratings for Alpha Tau MedicalNovember 16, 2023 | msn.comAlpha Tau Medical GAAP EPS of $0.31October 30, 2023 | finance.yahoo.comAlpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing FacilitySeptember 16, 2023 | finance.yahoo.comHere's Why We're Not Too Worried About Alpha Tau Medical's (NASDAQ:DRTS) Cash Burn SituationSeptember 14, 2023 | stockhouse.comAlpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel's Hadassah Medical CenterAugust 24, 2023 | finance.yahoo.comAlpha Tau Medical to Participate in September Investor ConferencesAugust 17, 2023 | finance.yahoo.comAlpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRTAugust 2, 2023 | finance.yahoo.comAlpha Tau Medical to Present at the Emerging Growth Conference on August 9th, 2023May 25, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Alpha Tau Medical Ltd (DRTS)See More Headlines Company Calendar Last Earnings5/20/2024Today6/11/2024Next Earnings (Estimated)8/26/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryN/A Current SymbolNASDAQ:DRTS CUSIPN/A CIK1871321 Webhealthcarecapitalcorp.com Phone972-3577-4115FaxN/AEmployees121Year FoundedN/APrice Target and Rating Average Stock Price Target$12.00 High Stock Price Target$23.00 Low Stock Price Target$8.00 Potential Upside/Downside+421.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage4 Analysts Profitability EPS (Most Recent Fiscal Year)($0.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-29,160,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-33.47% Return on Assets-27.07% Debt Debt-to-Equity Ratio0.07 Current Ratio11.60 Quick Ratio11.60 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$1.21 per share Price / Book1.90Miscellaneous Outstanding Shares69,670,000Free Float42,151,000Market Cap$160.24 million OptionableOptionable Beta0.75 Key ExecutivesMr. Uzi Sofer (Age 54)CEO & Chairman Comp: $630kMr. Raphi Levy (Age 39)Chief Financial Officer Comp: $424kMr. Amnon Gat (Age 49)Chief Operations Officer Comp: $340kMr. Peter M. Melnyk (Age 62)Chief Commercial Officer Comp: $376kDr. Robert B. Den M.D. (Age 45)Chief Medical Officer & Member of Scientific Advisory Board Comp: $401kMr. Ronen Segal (Age 51)Chief Technology Officer Comp: $380kProf. Yona Keisari (Age 77)Chief Scientific Officer & Member of Scientific Advisory board Ms. Rebecca BeckerVice President of legalProf. Itzhak Kelson (Age 84)Chief Physics Officer & Member of Scientific Advisory Board Ms. Yael Zeiger (Age 41)Corporate Controller More ExecutivesKey CompetitorsSurmodicsNASDAQ:SRDXParagon 28NYSE:FNASI-BONENASDAQ:SIBNIradimedNASDAQ:IRMDOrthofix MedicalNASDAQ:OFIXView All CompetitorsInstitutional OwnershipLevin Capital Strategies L.P.Bought 8,641 shares on 5/16/2024Ownership: 0.486%USAdvisors Wealth Management LLCBought 10,238 shares on 5/2/2024Ownership: 0.015%Satovsky Asset Management LLCSold 9,836 shares on 4/23/2024Ownership: 0.070%View All Institutional Transactions DRTS Stock Analysis - Frequently Asked Questions Should I buy or sell Alpha Tau Medical stock right now? 4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alpha Tau Medical in the last year. There are currently 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" DRTS shares. View DRTS analyst ratings or view top-rated stocks. What is Alpha Tau Medical's stock price target for 2024? 4 Wall Street analysts have issued 12 month target prices for Alpha Tau Medical's shares. Their DRTS share price targets range from $8.00 to $23.00. On average, they predict the company's stock price to reach $12.00 in the next twelve months. This suggests a possible upside of 421.7% from the stock's current price. View analysts price targets for DRTS or view top-rated stocks among Wall Street analysts. How have DRTS shares performed in 2024? Alpha Tau Medical's stock was trading at $3.01 on January 1st, 2024. Since then, DRTS shares have decreased by 23.6% and is now trading at $2.30. View the best growth stocks for 2024 here. When is Alpha Tau Medical's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, August 26th 2024. View our DRTS earnings forecast. How were Alpha Tau Medical's earnings last quarter? Alpha Tau Medical Ltd. (NASDAQ:DRTS) released its earnings results on Monday, May, 20th. The company reported ($0.11) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.13) by $0.02. Who are Alpha Tau Medical's major shareholders? Alpha Tau Medical's stock is owned by a variety of institutional and retail investors. Top institutional investors include Levin Capital Strategies L.P. (0.49%), Satovsky Asset Management LLC (0.07%) and USAdvisors Wealth Management LLC (0.01%). How do I buy shares of Alpha Tau Medical? Shares of DRTS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:DRTS) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Alpha Tau Medical Ltd. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Tau Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.